Phenazopyridine Hydrochloride
Product Images NDC 70985-028

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phenazopyridine Hydrochloride (NDC 70985-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Drug Ocean Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Phenazopyridine HCl Tablets- Blister (Phenazopyridine Hydrochloride Tablets 95 mg)

FDA Label Image

Phenazopyridine HCl Tablets- Carton (Phenazopyridine Hydrochloride Tablets Carton 95mg 30 Tablets)

Phenazopyridine HCl Tablets- Carton (Phenazopyridine Hydrochloride Tablets Carton 95mg 30 Tablets)
This text contains information on a medication distributed under the brand name "Drug Facts." The active ingredient in each tablet is Phenazopyridine Hydrochloride, which is used as a urinary tract analgesic. The product is manufactured in India and is designed to provide relief from urinary pain, burning, urgency, and frequency associated with urinary tract infections. The text provides instructions for usage, warnings, precautions, and details on inactive ingredients. It also includes dosage directions for adults and children over 12 years old, as well as guidance for pregnant or breastfeeding individuals. Additionally, the text warns about potential side effects and advises users to consult a doctor if symptoms persist or if an adverse reaction is suspected.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.